International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported that Kennerman Associates, Inc. has picked up 195,304,771 of common stock as of 2017-05-01.

The acquisition brings the aggregate amount owned by Kennerman Associates, Inc. to a total of 195,304,771 representing less than 43.3% stake in the company.

For those not familiar with the company, International Isotopes Inc. is a manufacturer of nuclear medicine calibration and reference standards, a range of products, including cobalt teletherapy sources, and a selection of radioisotopes and radiochemicals for medical research and clinical devices. Its segments include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with Single Photon Emission Computed Tomography (SPECT) imaging, patient positioning and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Cobalt Products include the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy or various industrial applications, and recycling of expended cobalt sources. Radiochemical Products include production and distribution of various isotopically pure radiochemicals.

A glance at International Isotopes Inc. (OTCBB:INIS)’s key stats reveals a current market capitalization of 28.49 Million based on 406.96 Million shares outstanding and a price at last close of $0.07 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2015-03-06, Grosso picked up 1,766,667 at a purchase price of $0.02. This brings their total holding to 19,845,926 as of the date of the filing.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on International Isotopes Inc.  (OTCBB:INIS) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Richard Schwarz is a veteran analyst in the small cap space, with a particular focus on the development stage biotech sector. He is a native of Canada, and attended NYU before working for a host of big name pharma outfits.

Leave a Reply

Your email address will not be published. Required fields are marked *


TOP